Digital-First Care and Affordability: Our Leaders Share Insights with pharmaphorum

Patients today expect care to be as seamless as buying online: on demand, transparent and personalized – pharma must adapt. 

Brian Laird, President, Patient Services, EVERSANA and Deanna Horner, SVP and Chief Pharmacy Officer, Waltz Health, explored how digital-first models, affordability and direct-to-patient strategies are reshaping the patient journey in pharmaphorum’s Deep Dive Magazine. 

Meeting Patients Where They Are 

Patients today want convenience, transparency and personalization. From telehealth and apps to integrated care teams, the expectation is clear: healthcare should fit into their lives, not the other way around. 

“Patients are consumers first. They have choices and they expect clarity on pricing and seamless ways to connect with clinicians.” – Brian Laird 

Continuity of Care in a Hybrid World 

With patients moving between wellness apps, telehealth and traditional clinics, continuity of care is critical. Our approach combines partnerships, integrated services and data-driven solutions to reduce therapy abandonment and improve adherence.  

Affordability: The Biggest Barrier 

Financial challenges remain one of the hardest gaps to bridge. Horner emphasizes that affordability programs must go beyond traditional models to truly remove barriers and keep patients on therapy. Our team works to optimize these programs, ensuring patients can access and afford the treatments they need. 

Direct-to-Patient: Beyond Communication 

Direct-to-patient models have evolved from marketing channels to comprehensive care delivery systems. EVERSANA DIRECT™ Commercialization integrates marketing, diagnosis, prescription fulfillment, adherence and affordability into one streamlined approach powered by AI and digital tools. 

Looking Ahead 

The future of pharma is high-tech and high-touch. Integrated ecosystems, AI-driven personalization and home-based care options will define the next era of patient engagement. 

 “We have the opportunity to create better access to drugs, reduce costs and make a difference in lives.” – Deanna Horner 

Learn more about EVERSANA DIRECT™ Commercialization 

---

Connect With An Expert!